Info Edge’s subsidiary, Redstart Labs, is set to acquire an additional stake in the Bengaluru-based healthcare startup, Brainsight Technology, for a cash payment of ₹3 crore. Following this acquisition, Redstart Labs’ shareholding in Brainsight Technology will increase from 4.68% to 5.27%.
Founded in 2019, Brainsight Technology specializes in healthcare solutions using AI-based functional brain mapping techniques. The company is known for its innovative approaches to analyzing and mapping brain functions, offering advanced solutions in the healthcare sector.
Info Edge, a well-established name in the Indian internet industry, has built a diverse investment portfolio over the years. Its portfolio includes major brands such as Zomato, PB Fintech (Policybazaar and Paisabazaar), and Adda247, demonstrating its significant presence across multiple sectors, including food delivery, fintech, and education technology.
The strategic move to increase its stake in Brainsight Technology highlights Info Edge’s commitment to fostering innovation in healthcare. By leveraging Redstart Labs’ investment capabilities, Info Edge is supporting startups that utilize cutting-edge technologies like artificial intelligence to address critical challenges in the medical field.
This development reflects Info Edge’s consistent efforts to diversify its investments and strengthen its presence in emerging markets. With the growing demand for AI-driven healthcare solutions, this increased stake in Brainsight Technology positions Info Edge to tap into the expanding healthcare innovation ecosystem in India.
As Info Edge continues to nurture its portfolio, its investments in companies like Brainsight Technology signify the company’s forward-thinking approach to growth and innovation in the technology-driven startup landscape.
Recently, a news has come out according to which Redstart Labs, a subsidiary of online classified company Info Edge, is all set to acquire additional stake in Brainsight Technology by paying Rs 3 crore in cash. In this case, the stake of the Bengaluru-based health care startup company will increase to 5.27% and this is a big update.